Elsevier

Neuropharmacology

Volume 28, Issue 1, January 1989, Pages 89-97
Neuropharmacology

Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain

https://doi.org/10.1016/0028-3908(89)90073-7Get rights and content

Abstract

Drugs administered during the perinatal period reach the developing organism at the vulnerable stage of intensive brain histogenesis and cytodifferentiation. They may interfere with the programme of developmental processes in the brain and lead to disturbances at the cellular/subcellular level and to biochemical alterations. These abnormalities form the basis for the functional pathology which becomes apparent gradually during maturation or even in adulthood as neuropsycho-behavioural deviations.

A model experimental study in rats was carried out with synthetic glucocorticoids, which are widely used in obstetrics and neonatology for the prevention and treatment of neonatal idiopathic respiratory distress syndrome. As the developmental stage of the brain of the human foetus in late pregnancy closely resembles the ontogenetic phases of the brain of the rat in the early postnatal period, the neonate rat was taken as a model. The administration of dexamethasone to 7-day-old rats resulted in significant depletion of glucocorticoid receptors from the cytosol of the brain in a dose-dependent manner, beginning with the dose of 0.04 mg/kg (s.c.), i.e. a dose one order lower than the clinical dose used in obstetrics (0.4–0.5 mg/kg). Long-term follow-up of a single neonatal injection of dexamethasone (0.2 or 1 mg/kg s.c. on postnatal day 7) revealed an acceleration of some developmental landmarks in the preweaning period (incisor eruption, eye opening, motor skill) on the one hand, but a retardation of body growth and vaginal opening on the other hand. Adult animals exhibited a deficit in motor co-ordination, behavioural deviations (hyperactivity with stereotypy, decreased adaptability, increased emotional reactivity) and disturbances in reproduction in both males and females. Maldevelopment of the brain appeared in terms of retardation in growth with permanent deficit in weight of the cerebellum, reduced size of cells in the cerebellum and hippocampus and decreased concentration of noradrenaline in the hypothalamus. As all the deviations described were induced by a single neonatal injection of doses corresponding to the clinical dose in obstetrics and neonatology, a high behavioural tetatogenic risk of using glucocorticoids in the perinatal period may be expected.

References (35)

  • P.L. Ballard et al.

    Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome

    J. clin. Invest.

    (1975)
  • R.A. Ballard et al.

    Long-term outcome after prenatal glucocorticoid therapy

    Clin. Res.

    (1985)
  • O. Benešová et al.

    Brain glucocorticoid receptors and their role in behavioural teratogenicity of synthetic glucocorticoids

    Arch. Toxic.

    (1985)
  • O. Benešová et al.

    Brain Maldevelopment and Drugs

    (1984)
  • M.C. Bohn

    Glucocorticoid induced teratologies of the nervous system

  • M.C. Bohn et al.

    The effects of neonatal hydrocortisone on rat cerebellar development

    Dev. Neurosci.

    (1978)
  • Collaborative Group on Antenatal Steroid Therapy

    Effects of antenatal dexamethasone administration in the infant: long-term follow-up

    J. Pediat.

    (1984)
  • Cited by (112)

    • Effects of corticosterone injections in mid-to-late mouse postnatal development on adult motor activity and coordination

      2021, Neuroscience Research
      Citation Excerpt :

      However, body weight may decrease when glucocorticoids are given prior to the second postnatal week. Rat pups injected with dexamethasone on P3-P6 weighed less than controls at P4-P8, P14, and P20 (Flagel et al., 2002) and those injected on either P4 (DeKosky et al., 1982) or P7 (Benesova and Pavlik, 1989; Ferguson and Holson, 1999; Ferguson et al., 2001) weighed less as adults. Other neonatal treatments affect only neonatal measures, as when rat pups injected with dexamethasone on P3 weighed less at P7-P28 but not P112 (Ferguson and Holson, 1999) and mouse pups injected with dexamethasone on P7, P9, and P11 weighed less at P9-P28 but not P43 (Maloney et al., 2011).

    • Coping with pregnancy after 9 months in the dark: Post-hibernation buffering of high maternal stress in arctic ground squirrels

      2016, General and Comparative Endocrinology
      Citation Excerpt :

      Though some exposure of the fetus to GCs is necessary, overexposure must be prevented. When GC levels are too high during pregnancy, they can cause fetal growth retardation, low birth weight, high reactivity of the stress axis, brain deformation, and defective motor coordination (Benešová and Pavlik, 1989; Schneider et al., 1999; Seckl and Holmes, 2007). Some of these consequences, such as the high reactivity, may be adaptive in the wild for offspring entering a high-stress environment, but because they are often studied in a laboratory or clinical setting, the response is not matched with the environment and manifests itself as disease.

    View all citing articles on Scopus
    View full text